Antares Pharma reported $3.34M in Loan Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Adamas Pharmaceuticals ADMS:US 124.48M 1.06M
Adma Biologics ADMA:US $ 94.36M 0.49M
Aerie Pharmaceuticals AERI:US $ 228.19M 6.17M
Ani Pharmaceuticals ANIP:US $ 186.06M 3.46M
Atrion ATRI:US 0 0
Becton, Dickinson and BDX:US $ 17110M 1410M
Cerus CERS:US $ 54.68M 7K
Eli Lilly And LLY:US $ 15522.4M 785.8M
Endo International Ordinary Shares ENDP:US $ 8070.77M 3.67M
Horizon Pharma HZNP:US $ 2557.86M 2.58M
JAZZ PHA JAZZ:US $ 6253.65M 241.68M
Meridian Bioscience VIVO:US $ 60M 10M
Pacira Pharmaceuticals PCRX:US $ 326.15M 4.44M
Revance Therapeutics RVNC:US $ 280.32M 0.32M
Rockwell Medical RMTI:US $ 14.09M 14.09M
Sientra SIEN:US $ 61.48M 853K
Staar Surgical STAA:US $ 0.02M 0M
Supernus Pharmaceuticals SUPN:US $ 374.79M 4.4M
Teva Pharmaceutical TEVA:IT 21.04B 565M
Teva Pharmaceutical Industries TEVA:US $ 21037M 565M
Zogenix ZGNX:US $ 155.87M 2.24M